Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Depreciation and Depletion (2020 - 2022)

Caribou Biosciences (CRBU) reported Depreciation and Depletion of $400000.0 for Q2 2022, up 100.0% year-over-year from $200000.0 in Q2 2021, and up 33.33% on a QoQ basis from $300000.0 in Q1 2022.

Caribou Biosciences (CRBU) has 3 years of Depreciation and Depletion data on file, last reported at $400000.0 in Q2 2022.

  • Quarterly Depreciation and Depletion rose 100.0% year-over-year to $400000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $301000.0 (down 66.56% YoY) and the FY2021 annual result came in at $1000.0, down 99.89% from the prior year.
  • Depreciation and Depletion grew to $400000.0 in Q2 2022 per CRBU's latest filing, from $300000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $400000.0 in Q2 2022 and bottomed at -$699000.0 in Q4 2021.
  • The 3-year median for Depreciation and Depletion is $200000.0 (2020), against an average of $155666.7.
  • The widest annual swing landed in 2021, when Depreciation and Depletion plunged 449.5%; it then surged 100.0% in 2022.
  • Tracing CRBU's Depreciation and Depletion over 3 years: stood at $200000.0 in 2020, then sank by 449.5% to -$699000.0 in 2021, then jumped by 157.22% to $400000.0 in 2022.
  • Per Business Quant, the three latest CRBU Depreciation and Depletion figures stand at $400000.0 (Q2 2022), $300000.0 (Q1 2022), and -$699000.0 (Q4 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1,395.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Caribou Biosciences 232.46 Mn 114.84 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 400,000.00
Jun 30, 2022 400,000.00
Mar 31, 2022 300,000.00
Mar 31, 2022 300,000.00
Dec 31, 2021 -699,000.00
Dec 31, 2021 -699,000.00
Sep 30, 2021 300,000.00
Sep 30, 2021 300,000.00
Jun 30, 2021 200,000.00
Jun 30, 2021 200,000.00
Mar 31, 2021 200,000.00
Mar 31, 2021 200,000.00
Dec 31, 2020 200,000.00
Dec 31, 2020 200,000.00
Sep 30, 2020 300,000.00
Sep 30, 2020 300,000.00
Jun 30, 2020 200,000.00
Jun 30, 2020 200,000.00